Diagnos Laboratorium Utama Tbk. vs Winner Nusantara Jaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Winner Nusantara Jaya Tbk. trades at Rp21 (market cap 109.94B, 8.79M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.8× Winner Nusantara Jaya Tbk.'s market cap, and Winner Nusantara Jaya Tbk. is more actively traded (8.79M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | WINR | |
|---|---|---|
Market Cap | 310.75B | 109.94B |
Volume | 963.6K | 8.79M |
Lot | 9.64K | 87.89K |
Turnover | 217.67M | 187.42M |
Average Price | 225.89 | 21.32 |
Value | 217.67M | 187.42M |
Indicative Equilibrium Price | 226 | 21 |
Indicative Equilibrium Volume | 1K | 32.31K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Winner Nusantara Jaya Tbk (the Company) was established based on notarial deed No. 10 dated October 10, 2007 of Anly Cenggana, S.H., notary in Batam.
Read more on WINR →